Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Abound Bio logo — #PioneeringForPatients | A Galapagos company

Abound Bio

#PioneeringForPatients | A Galapagos company

Founded 2019 United States Pittsburgh, United States 3 employees Biotechnology, Health Care +1

General Information

Company Name Abound Bio
Founded Year 2019
Location United States Pittsburgh, United States +1
Employees 3
Industries Biotechnology, Health Care, Health and Wellness
Social

Get notified when Abound Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Abound Bio

Abound Bio is a biotechnology company with a mission to develop innovative antibody-based therapeutics to address unmet medical needs in cancer and infectious diseases. Led by renowned experts in therapeutic antibodies, infectious diseases, and cancer, the company has a successful track record in developing biotherapeutics, licensing, and partnerships. In 2022, Abound Bio was acquired by Galapagos, a fully integrated biotechnology company aiming to transform patient outcomes through groundbreaking science and innovation. As a result of the acquisition, all updates, news, and insights will now be shared on the Galapagos’ page, while the Abound Bio page will serve for historical purposes. For further details on the acquisition, refer to the press release from June 22, 2022: Press Release. Abound Bio's focus on pioneering therapies demonstrates its potential to make significant contributions to the biotechnology, healthcare, and health and wellness industries.

Taxonomy: Antibody Engineering, Antibody Discovery, Antibody Therapeutics, Phage Display, Immunotherapy, Cancer, Infectious Disease, Drug Development, Cell Therapies, Biological Therapeutics, Precision Medicine, Therapeutic Antibodies, Life Sciences, Biopharmaceuticals

No funding data available for Abound Bio yet.

Get notified when Abound Bio raises funding

Abound Bio Alternatives & Competitors

Abound Bio vs
CellPoint
CellPoint The Netherlands

CellPoint enables clinicians to treat hematological malignancies by retargeting patient immune cells...

49 employees
Biotechnology, Health Care
Abound Bio vs
Metsera
Metsera

Reducing the burden of obesity

Corporate
73 employees
Biotechnology, Pharmaceutical
Abound Bio vs
BioNTech SE
BioNTech SE Germany

Our vision is to harness the power of the immune system to develop novel therapies against cancer &...

5193 employees
Health Care

FAQ About Abound Bio

#PioneeringForPatients | A Galapagos company
Abound Bio was founded in 2019.
Abound Bio is headquartered in Pittsburgh, United States.
Abound Bio operates in the following industries: Biotechnology, Health Care, Health and Wellness.
Abound Bio has approximately 3 employees.
Top alternatives and competitors to Abound Bio include CellPoint, Metsera, BioNTech SE, Tsingke Biotech, AFFiRiS AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Abound Bio and CellPoint are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Abound Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy